Literature DB >> 15140986

Suppression of proinflammatory cytokine expression by herpes simplex virus type 1.

Trine H Mogensen1, Jesper Melchjorsen, Lene Malmgaard, Antonella Casola, Søren R Paludan.   

Abstract

Viral immune evasion strategies are important for establishment and maintenance of infections. Many viruses are in possession of mechanisms to counteract the antiviral response raised by the infected host. Here we show that a herpes simplex virus type 1 (HSV-1) mutant lacking functional viral protein 16 (VP16)-a tegument protein promoting viral gene expression-induced significantly higher levels of proinflammatory cytokines than wild-type HSV-1. This was observed in several cell lines and primary murine macrophages, as well as in peritoneal cells harvested from mice infected in vivo. The enhanced ability to stimulate cytokine expression in the absence of VP16 was not mediated directly by VP16 but was dependent on the viral immediate-early genes for infected cell protein 4 (ICP4) and ICP27, which are expressed in a VP16-dependent manner during primary HSV infection. The virus appeared to target cellular factors other than interferon-induced double-stranded RNA-activated protein kinase R (PKR), since the virus mutants remained stronger inducers of cytokines in cells stably expressing a dominant-negative mutant form of PKR. Finally, mRNA stability assay revealed a significantly longer half-life for interleukin-6 mRNA after infection with the VP16 mutant than after infection with the wild-type virus. Thus, HSV is able to suppress expression of proinflammatory cytokines by decreasing the stability of mRNAs, thereby potentially impeding the antiviral host response to infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15140986      PMCID: PMC415838          DOI: 10.1128/JVI.78.11.5883-5890.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

Review 1.  Repression of viral transcription during herpes simplex virus latency.

Authors:  C M Preston
Journal:  J Gen Virol       Date:  2000-01       Impact factor: 3.891

Review 2.  Chemokines: immunology's high impact factors.

Authors:  C R Mackay
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

Review 3.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

4.  Inhibition of dendritic cell maturation by herpes simplex virus.

Authors:  M Salio; M Cella; M Suter; A Lanzavecchia
Journal:  Eur J Immunol       Date:  1999-10       Impact factor: 5.532

5.  A viral inhibitor of peptide transporters for antigen presentation.

Authors:  K Früh; K Ahn; H Djaballah; P Sempé; P M van Endert; R Tampé; P A Peterson; Y Yang
Journal:  Nature       Date:  1995-06-01       Impact factor: 49.962

6.  Potential role of PKR in double-stranded RNA-induced macrophage activation.

Authors:  L B Maggi; M R Heitmeier; D Scheuner; R J Kaufman; R M Buller; J A Corbett
Journal:  EMBO J       Date:  2000-07-17       Impact factor: 11.598

7.  The role of the UL41 gene of herpes simplex virus type 1 in evasion of non-specific host defence mechanisms during primary infection.

Authors:  T Suzutani; M Nagamine; T Shibaki; M Ogasawara; I Yoshida; T Daikoku; Y Nishiyama; M Azuma
Journal:  J Gen Virol       Date:  2000-07       Impact factor: 3.891

8.  DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo.

Authors:  J Sin; J J Kim; C Pachuk; C Satishchandran; D B Weiner
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

9.  Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein.

Authors:  J Poppers; M Mulvey; D Khoo; I Mohr
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

10.  Herpes simplex virus type 2 induces secretion of IL-12 by macrophages through a mechanism involving NF-kappaB.

Authors:  Lene Malmgaard; Søren R Paludan; Søren C Mogensen; Svend Ellermann-Eriksen
Journal:  J Gen Virol       Date:  2000-12       Impact factor: 3.891

View more
  24 in total

Review 1.  Bats: important reservoir hosts of emerging viruses.

Authors:  Charles H Calisher; James E Childs; Hume E Field; Kathryn V Holmes; Tony Schountz
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

2.  Human cytomegalovirus immediate-early 2 protein IE86 blocks virus-induced chemokine expression.

Authors:  R Travis Taylor; Wade A Bresnahan
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 3.  Pathogen recognition and inflammatory signaling in innate immune defenses.

Authors:  Trine H Mogensen
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

4.  Interactome and Proteome Dynamics Uncover Immune Modulatory Associations of the Pathogen Sensing Factor cGAS.

Authors:  Krystal K Lum; Bokai Song; Joel D Federspiel; Benjamin A Diner; Timothy Howard; Ileana M Cristea
Journal:  Cell Syst       Date:  2018-11-21       Impact factor: 10.304

5.  Enhanced expression of IFI16 and RIG-I in human third-trimester placentas following HSV-1 infection.

Authors:  A Jabłońska; M Studzińska; P Suski; J Kalinka; E Paradowska
Journal:  Clin Exp Immunol       Date:  2018-08       Impact factor: 4.330

6.  Human cytomegalovirus blocks tumor necrosis factor alpha- and interleukin-1beta-mediated NF-kappaB signaling.

Authors:  Christina Montag; Jutta Wagner; Iris Gruska; Christian Hagemeier
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

Review 7.  Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection.

Authors:  Jairam R Lingappa; Connie Celum
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 8.  Recognition of herpes simplex viruses: toll-like receptors and beyond.

Authors:  Yijie Ma; Bin He
Journal:  J Mol Biol       Date:  2013-11-19       Impact factor: 5.469

Review 9.  Role of Inflammation in Virus Pathogenesis during Pregnancy.

Authors:  Anna Chudnovets; Jin Liu; Harish Narasimhan; Yang Liu; Irina Burd
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

Review 10.  Pathobiology and treatment of viral keratitis.

Authors:  Raghuram Koganti; Tejabhiram Yadavalli; Raza Ali Naqvi; Deepak Shukla; Afsar R Naqvi
Journal:  Exp Eye Res       Date:  2021-02-06       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.